Myelodysplastic Syndrome — Trials

Myelodysplastic Syndrome — Trials · CancerIndex

Clinical trials

Registered studies

1,702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 336
Recruiting: 196
Ph III recruiting: 9
Growth YoY: +2.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 33.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (307)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04730258	A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML(TWT-202)	active not recruiting	Phase 1 / Phase 2	72	Treadwell Therapeutics, IncINDUSTRY	3	May 18, 2025	clinicaltrials
NCT04202835	ATG Plus PTCy vs ATG for CGVHD Prophylaxis	active not recruiting	Phase 2	80	McMaster UniversityOTHER	2	May 11, 2025	clinicaltrials